Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Microbial Corrosion01:24

Microbial Corrosion

Microbiologically Influenced Corrosion (MIC) is a significant form of material degradation caused by the metabolic activities of microorganisms. This phenomenon poses substantial challenges across various industries, including oil and gas, maritime, and water treatment sectors.MIC occurs when microorganisms, such as bacteria, archaea, and fungi, colonize metal surfaces, forming biofilms that alter the local electrochemical environment. These biofilms can lead to the production of corrosive...
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Chemical Agents for Microbial Control01:27

Chemical Agents for Microbial Control

Chemicals play important roles in controlling microbial growth by targeting microbial structures and functions as sanitizers, antiseptics, disinfectants, and sterilants.Alcohols are commonly used sanitizers, effectively disrupting lipid membranes, which compromises cell integrity. They are also used as antiseptics and disinfectants due to their rapid action and versatility.Phenols and their derivatives phenolics , known for denaturing proteins and disrupting cell membranes, are particularly...
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Implementing the collaborative chronic care model for mental health: a nonrandomized clinical trial.

Implementation science communications·2026
Same author

Duration of clinically meaningful improvement in pain as a patient-centered endpoint in acute pain trials.

Pain·2026
Same author

Provider and leadership attitudes toward telemental health at sites with high levels of video, phone, and in-person care: A qualitative analysis.

Psychological services·2026
Same author

Complication outcomes in retroauricular interpolated flaps after Mohs surgery: A single-center retrospective study.

Journal of the American Academy of Dermatology·2026
Same author

Impact of Wetting-Drying Cycles on Iron Oxide Transformations and Contaminant Mobilization in a Replica Legacy Radioactive Waste Trench.

Environmental science & technology·2026
Same author

Response to Xu et al., "Letter to Editor 'Mohs micrographic surgery reduces the risk of reconstruction with positive margins, repeat surgeries, and time to definitive reconstruction compared to conventional excision of hand and foot melanomas: A retrospective cohort study'".

Journal of the American Academy of Dermatology·2026
Same journal

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Science (New York, N.Y.)·2026
Same journal

Local signals, systemic decline.

Science (New York, N.Y.)·2026
Same journal

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026
Same journal

Computing in a memory with physics.

Science (New York, N.Y.)·2026
Same journal

Retraction.

Science (New York, N.Y.)·2026
Same journal

Making time.

Science (New York, N.Y.)·2026
関連記事をすべて見る

関連する実験動画

Updated: Jul 3, 2026

Establishing the Minimal Bactericidal Concentration of an Antimicrobial Agent for Planktonic Cells (MBC-P) and Biofilm Cells (MBC-B)
06:36

Establishing the Minimal Bactericidal Concentration of an Antimicrobial Agent for Planktonic Cells (MBC-P) and Biofilm Cells (MBC-B)

Published on: January 2, 2014

微生物殺菌剤は枯れるか枯れるか?

Robert M Grant1, Dean Hamer, Thomas Hope

  • 1J. David Gladstone Institutes, University of California-San Francisco, San Francisco, CA 94518, USA.

Science (New York, N.Y.)
|July 26, 2008
PubMed
まとめ
この要約は機械生成です。

HIV-1予防のための微生物殺菌剤の研究は,試験の失敗と不適切な戦略のために課題に直面しています. 将来の成功には,より良い意思決定と,新しいHIV予防方法を開発するための検証された動物モデルが必要です.

関連する実験動画

Last Updated: Jul 3, 2026

Establishing the Minimal Bactericidal Concentration of an Antimicrobial Agent for Planktonic Cells (MBC-P) and Biofilm Cells (MBC-B)
06:36

Establishing the Minimal Bactericidal Concentration of an Antimicrobial Agent for Planktonic Cells (MBC-P) and Biofilm Cells (MBC-B)

Published on: January 2, 2014

科学分野:

  • * 感染症
  • *公衆衛生について
  • * 薬物開発

背景:

  • *HIV-1性感染症の予防のための殺菌剤の研究は,大きな挫折に直面しています.
  • * 過去の有効性試験は,微生物殺菌剤に対する信頼を蝕み,失望的な結果をもたらしました.
  • * 課題としては,調整の欠如や,第3相試験で検証されていないターゲットの使用が挙げられます.

研究 の 目的:

  • *最近の研究が失敗した後に微生物殺菌剤の研究が直面している課題を分析する.
  • * 効果的なHIV-1予防戦略の開発を妨げている重要な要因を特定する.
  • * 将来の微生物殺菌剤候補を進めるために必要な改善を提案する.

主な方法:

  • * 過去の微生物殺菌剤の有効性試験のレビューと研究調整.
  • *臨床試験への候補者の進出のための意思決定プロセスの分析.
  • * 臨床前開発における動物モデルの役割を強調する.

主要な成果:

  • *複数の有効性試験の失望した結果は,かなりの課題を生み出しました.
  • * 調整の欠如と検証されていない科学的目標の選択は,進歩を妨げています.
  • *HIV-1予防のための微生物殺菌剤の有効性に関して不信感が生じています.

結論:

  • *この分野では,新しい微生物殺菌剤候補が臨床試験にどのように選択されるのかを批判的に再評価する必要があります.
  • *適切な動物モデルを戦略的に使用することは,次世代の微生物殺菌剤の進歩に不可欠です.
  • * HIV-1予防研究に対する信頼を回復し,研究に成功するためには,調整の改善と検証された科学的目標が不可欠です.